Literature DB >> 12527383

Differential incorporation of biotinylated polyamines by transglutaminase 2.

Ju Hong Jeon1, Chai Wan Kim, Dong Myung Shin, Kyu il Kim, Sung Yup Cho, Joon Cheol Kwon, Kyung Ho Choi, Heun Soo Kang, In Gyu Kim.   

Abstract

Polyamine incorporation or cross-linking of proteins, post-translational modifications mediated by transglutaminase 2 (TGase 2), have been implicated in a variety of physiological functions including cell adhesion, extracellular matrix formation and apoptosis. To better understand the intracellular regulation mechanism of TGase 2, the properties of biotinylated polyamines as substrates for determining in situ TGase activity were analyzed. We synthesized biotinylated spermine (BS), and compared the in vitro and in situ incorporation of BS with that of biotinylated pentylamine (BP), which is an artificial polyamine derivative. When measured in vitro, BP showed a significantly higher incorporation rate than BS. In contrast, in situ incorporation of both BS and BP was not detected even in TGase 2-overexpressed 293 cells. Cells exposed to high calcium showed a marked increase of BP incorporation but not of BS. These data indicate that the in situ activity of TGase 2 gives different results with different substrates, and suggest the possibility of overrepresentation of in situ TGase 2 activity when assayed with BP. Therefore, careful interpretation or evaluation of in situ TGase 2 activity may be required.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527383     DOI: 10.1016/s0014-5793(02)03836-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of Bax.

Authors:  Sung-Yup Cho; Jin-Haeng Lee; Han-Dong Bae; Eui Man Jeong; Gi-Yong Jang; Chai-Wan Kim; Dong-Myung Shin; Ju-Hong Jeon; In-Gyu Kim
Journal:  Exp Mol Med       Date:  2010-09-30       Impact factor: 8.718

2.  Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death.

Authors:  Sung-Yup Cho; Eui Man Jeong; Jin-Haeng Lee; Hyo-Jun Kim; Jisun Lim; Chai-Wan Kim; Dong-Myung Shin; Ju-Hong Jeon; Kyungho Choi; In-Gyu Kim
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

3.  Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates.

Authors:  Sandra Hauser; Paul Sommerfeld; Johanna Wodtke; Christoph Hauser; Paul Schlitterlau; Jens Pietzsch; Reik Löser; Markus Pietsch; Robert Wodtke
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

4.  Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine.

Authors:  Ju-Hong Jeon; Kyung-Ho Choi; Sung-Yup Cho; Chai-Wan Kim; Dong-Myung Shin; Joon-Cheol Kwon; Kye-Yong Song; Sang-Chul Park; In-Gyu Kim
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

5.  Transglutaminase 2 mediates transcriptional regulation through BAF250a polyamination.

Authors:  Hyo-Jun Kim; Jin-Haeng Lee; Sung-Yup Cho; Ju-Hong Jeon; In-Gyu Kim
Journal:  Genes Genomics       Date:  2021-02-08       Impact factor: 1.839

6.  Detection of transglutaminase activity using click chemistry.

Authors:  Remon van Geel; Marjoke F Debets; Dennis W P M Löwik; Ger J M Pruijn; Wilbert C Boelens
Journal:  Amino Acids       Date:  2011-12-17       Impact factor: 3.520

7.  Transglutaminase 2 mediates hypoxia-induced selective mRNA translation via polyamination of 4EBPs.

Authors:  Sung-Yup Cho; Seungun Lee; Jeonghun Yeom; Hyo-Jun Kim; Jin-Haeng Lee; Ji-Woong Shin; Mee-Ae Kwon; Ki Baek Lee; Eui Man Jeong; Hee Sung Ahn; Dong-Myung Shin; Kyunggon Kim; In-Gyu Kim
Journal:  Life Sci Alliance       Date:  2020-02-19

8.  Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers.

Authors:  Sung-Yup Cho; Yumi Oh; Eui Man Jeong; Sanghui Park; Dakeun Lee; Xiaorui Wang; Qiqi Zeng; Hongyu Qin; Fang Hu; Hui Gong; Xi Liu; Guanjun Zhang; Deukchae Na; Jieun Lee; Jeesoo Chae; Yun-Suhk Suh; Seong-Ho Kong; Hyuk-Joon Lee; Jong-Il Kim; Hansoo Park; Chengsheng Zhang; Han-Kwang Yang; Charles Lee
Journal:  Exp Mol Med       Date:  2020-05-28       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.